*The following content is generated by AI and is for reference only.
Overview
Vonoprazan Fumarate (TAK-438) is a potent potassium-competitive acid blocker (P-CAB) developed for gastrointestinal therapy. Its core synthesis involves precise fumaric acid salt formation to ensure stability and bioavailability. The molecular formula is C19H20F3N5O4S with CAS No. 1267856-78-9.
Application
- Gastrointestinal disorders: Treatment of gastroesophageal reflux disease (GERD).
- Duodenal ulcer management: Rapid healing and symptom relief protocols.
- H. pylori eradication: Component in triple or quadruple antibiotic regimens.
Precautions
Contraindicated in patients with known hypersensitivity to vonoprazan or fumarates. Storage requires protection from moisture and light at controlled room temperature. Clinical use mandates monitoring of liver function and potential drug-drug interactions due to CYP inhibition profiles.